CINCINNATI--(BUSINESS WIRE)--Oct. 15, 2003--Meridian Bioscience,
Inc., Cincinnati, Ohio (Nasdaq:VIVO) today announced that Forbes has
recognized it as one of the "200 Best Growth Companies in America", as
reported in their October 27, 2003 edition.
The Forbes 200 Best Growth Companies in America list is selected
from a database of 3,500 candidates whose last 12-month sales range
between $5 million and $600 million. Additional qualification criteria
included profitability tests and liquidity.
William J. Motto, Chairman and Chief Executive Officer, commented,
"We are pleased to have been recognized by Forbes Magazine as one of
the 200 Best Small Companies in America. This recognition is a tribute
to the efforts of all Meridian Bioscience employees."
Meridian is a fully integrated life science company that
manufactures, markets and distributes a broad range of innovative
diagnostic test kits, purified reagents and related products and
offers biopharmaceutical enabling technologies. Utilizing a variety of
methods, these products provide accuracy, simplicity and speed in the
early diagnosis and treatment of common medical conditions, such as
gastrointestinal, viral, urinary and respiratory infections. All
Meridian products are used outside of the human body and require
little or no special equipment. The Company's products are designed to
enhance patient well-being while reducing the total outcome costs of
healthcare. Meridian has strong market positions in the areas of
gastrointestinal and upper respiratory infections, serology,
parasitology and fungal disease diagnosis. In addition, Meridian is a
supplier of rare reagents and specialty biologicals. The Company
markets its products to hospitals, reference laboratories, research
centers, veterinary testing centers and physician offices in more than
60 countries around the world. The Company's shares are traded through
Nasdaq's National Market, symbol VIVO. Meridian's website address is
CONTACT: Meridian Bioscience, Inc.
John A. Kraeutler, 513-271-3700
SOURCE: Meridian Bioscience, Inc.